All analyses were performed in R (version 3.6.2). Descriptive statistics were used to summarize the SEER data according to patient and tumor characteristics. T-test and chi-squared test was performed to determine the differences in continuous and categorical patient characteristics between Oncotype DX usage (user vs. non-user). All tests were two-sided if applicable and statistical significance was assessed using an alpha of 0.05.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.